Novel therapeutic target discovered for estrogen receptor positive (ER+) breast cancer
Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers ...
Nov 17, 2017
0
12